PDS Biotechnology amends $6M promissory note with YA II PN, adding mandatory redemption and extended cure period

PDS Biotechnology Corp

Amendment to $6,000,000 promissory note dated June 15, 2026 with YA II PN, Ltd.
Requires weekly remittance notices for ATM proceeds and payment within 1 business day.
Extends Nasdaq listing deficiency cure period from 75 to 180 days.
New provision: 100% of net cash proceeds from non-ATM equity financings must be paid to holder within 5 business days.
Effective upon full payment of September 14, 2026 installment amount.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.